Prognosis of Patients with Paraneoplastic Syndromes Associated with Lung Cancer

Editorial

Austin J Pulm Respir Med 2014;1(2): 1006.

Prognosis of Patients with Paraneoplastic Syndromes Associated with Lung Cancer

Nobuhiro Kanaji*

Department of Internal Medicine, Division of Endocrinology and Metabolism, Hematology, Rheumatology and Respiratory Medicine, Kagawa University, Japan

*Corresponding author: Nobuhiro Kanaji, Department of Internal Medicine, Division of Endocrinology and Metabolism, Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan

Received: January 25, 2014; Accepted: February 19, 2014; Published: February 22, 2014

Editorial

Recent accumulating evidence has shown the influence of paraneoplastic syndromes on the survival of patients with lung cancer. This short review article focuses on the prognosis of patients with a variety of paraneoplastic syndromes associated with lung cancer (Tables 1 and 2), and describes the reported survival rates in a concrete manner.

Citation: Kanaji N. Prognosis of Patients with Paraneoplastic Syndromes Associated with Lung Cancer. Austin J Pulm Respir Med 2014;1(2): 1006. ISSN:2381-9022